Details for Patent: 8,425,934
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,425,934 protect, and when does it expire?
Patent 8,425,934 protects BRILINTA and is included in one NDA.
Protection for BRILINTA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-six patent family members in thirty-four countries.
Summary for Patent: 8,425,934
Title: | Pharmaceutical compositions |
Abstract: | The present invention relates to pharmaceutical compositions and, more particularly, to a pharmaceutical composition containing the compound {1S-[1.alpha.,2.alpha.,3.beta.(1S*,2R*),5.beta.]}-3-(7-{[2-(3,4-difluorop- henyl)cyclopropyl]amino}-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-- 3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol. |
Inventor(s): | Banks; Simon (Loughborough, GB) |
Assignee: | AstraZeneca AB (Sodertalje, SE) |
Application Number: | 11/841,030 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,425,934 |
Patent Claim Types: see list of patent claims | Composition; Compound; Formulation; Dosage form; |
Drugs Protected by US Patent 8,425,934
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | BRILINTA | ticagrelor | TABLET;ORAL | 022433-002 | Sep 3, 2015 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
Astrazeneca | BRILINTA | ticagrelor | TABLET;ORAL | 022433-001 | Jul 20, 2011 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,425,934
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 062451 | See Plans and Pricing | |||
Australia | 2007288541 | See Plans and Pricing | |||
Australia | 2011205164 | See Plans and Pricing | |||
Brazil | PI0715712 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |